ArticleClinical kidney journal2025
Association of albuminuria with incident atrial fibrillation in healthy older adults.
Article in Clinical kidney journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Development of atrial fibrillation (AF) portends an increased risk of adverse cardiovascular outcomes. Relatively little is known about the longitudinal association between urine albumin excretion and the development of AF, particularly among generally healthy older individuals. Methods: In a Results: UACR data were available for 19 114 participants (mean age 75.1 ± 4.5 years, 56.4% female, 91.3% White). The median follow-up was 4.7 years. UACR values were low: mean UACR was 2.1 ± 8.2 mg/mmol at baseline and 2.1 ± 3.3 mg/mmol at year 7. AF developed in 941 individuals. The rate of AF development was 1.11/100 person-years among participants with UACR <3 mg/mmol at baseline and 1.74/100 person-years among participants with UACR ≥3 mg/mmol at baseline. After adjustment for a broad range of factors, the hazard ratio for new-onset AF was 1.16 [95% confidence interval (CI) 1.11-1.21] when multiple imputation was used and 1.15 (95% CI 1.10-1.19) when only cases with complete baseline information were used. Conclusions: In older individuals who had low levels of albuminuria, doubling of UACR was associated with a 16% increase in the risk of new-onset AF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.